Skip to content

Based on Essence-function Relationship between Yin and Yang to explore the clinical therapeutic mechanism of Trionycis Carapax Partitioned moxibustion combined with auricular point sticking on perimenopausal insomnia patients

Based on Essence-function Relationship between Yin and Yang to explore the clinical therapeutic mechanism of Trionycis Carapax Partitioned moxibustion combined with auricular point sticking on perimenopausal insomnia patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000621
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-11-15
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

Control group (auricular point sticking group):auricular point sticking therapy
test group 1 (Trionycis Carapax Partitioned moxibustion group):Trionycis Carapax Partitioned moxibustion therapy
test group 2 (Trionycis Carapax Partitioned moxibustion combined with auricular point sticking group):Trionycis Carapax Partitioned moxibustion combined with auricular point sticking therapy

Sponsors

Nanjing Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: Perimenopausal insomnia patients with cardio-renal incompatibility in accordance with traditional Chinese and Western medicine diagnosis 2: The subjects were 40-60 years old 3: Pittsburgh Sleep Quality Index (PSQI) score =7 4: Primary school education level or above able to understand the content of this study Note: Patients must meet the above five criteria at the same time to enter the study. 5: Volunteer to participate in the study and sign the informed consent

Exclusion criteria

Exclusion criteria: 1: Pregnant and lactating women 2: Complicated with serious diseases of important organs suffering from malignant tumors or organic diseases such as heart brain lung liver kidney and other parts of the primary disease or infectious diseases of the whole body 3: People with mental disorders or cognitive understanding or expressive disabilities 4: Patients with internal genital organ resection and congenital defect of ovarian function 5: People who have used hormone replacement therapy or sleep medication in the last 3 months 6: Patients with severe allergies severe asthma skin collapse or bleeding disorders 7: Unable or unwilling to cooperate 8: Had participated in other clinical trials within 4 weeks prior to the start of this study Note: Patients who meet any of the above criteria will not be enrolled in this study.

Design outcomes

Primary

MeasureTime frame
Subjective observation indicators of insomnia symptoms;

Secondary

MeasureTime frame
Sex hormone test;Objective observation indicators of insomnia symptoms;Skin temperature monitoring;Subjective observation indicators of perimenopausal symptoms;

Countries

China

Contacts

Public ContactHan Sixuan

Nanjing Hospital of Chinese Medicine

2845395213@qq.com13851572452

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026